Related Experiment Video
Updated: Jun 1, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
The LKB1 complex-AMPK pathway: the tree that hides the forest
Michaël Sebbagh1, Sylviane Olschwang, Marie-Josée Santoni
1Inserm, U891, Centre de Recherche en Cancérologie de Marseille, 27 Blv Lei Roure, 13009, Marseille, France.
Familial Cancer
|June 10, 2011
Summary
The LKB1 serine threonine kinase, a tumor suppressor, is crucial in regulating cellular metabolism and growth. This review explores LKB1
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The serine threonine kinase LKB1, initially identified in C. elegans, is evolutionarily conserved and widely expressed.
- LKB1 mutations are linked to Peutz-Jeghers syndrome and are common in lung and cervical cancers, classifying it as a tumor suppressor gene.
- While LKB1's role in the AMPK/mTOR pathway is well-studied, other functions remain less understood.
Purpose of the Study:
- To review the regulation of LKB1 activity.
- To discuss LKB1's effectors and their roles.
- To explore LKB1's involvement in cell polarity.
Main Methods:
- Literature review of LKB1 research.
- Analysis of LKB1's role in cellular metabolism and growth.
- Investigation of LKB1's impact on cell polarity.
Main Results:
- LKB1 is a key regulator of the AMPK/mTOR pathway, connecting cellular metabolism, growth, and tumorigenesis.
- LKB1 mutations are implicated in various cancers, underscoring its tumor suppressor function.
- Emerging evidence suggests LKB1 plays a significant role in maintaining cell polarity.
Conclusions:
- LKB1 is a critical tumor suppressor involved in metabolic regulation and cell growth.
- Further research is needed to fully elucidate LKB1's diverse functions, particularly its role in cell polarity.
- Understanding LKB1 regulation and effectors is essential for cancer research and therapy.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...